Robert Salisbury

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 80% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Enzon Pharmaceuticals Inc May 1, 2005 - Oct. 8, 2013
Robert Salisbury's trades of Enzon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
358.11
Quantity 86,376 -37.9%
Value US$3,351,565
Transaction date
Purchase
Price
152.32
Quantity 56,232 -5.6%
Value US$2,439,282
Transaction date
Purchase
Price
18.44
Quantity 16,106 -45.8%
Value US$4,872,489
Transaction date
Purchase
Price
3.20
Quantity 600 +2.1%
Value US$1,920
Transaction date
Purchase
Price
3.19
Quantity 2,873 +11.4%
Value US$9,165
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2008-11-14 2008-11-13
B Purchase
86,376 -37.9%
358.11
US$3,351,565 		86,376 -37.9% 358.11 US$3,351,565
2008-11-14 2008-11-13
B Purchase
56,232 -5.6%
152.32
US$2,439,282 		56,232 -5.6% 152.32 US$2,439,282
2008-11-14 2008-11-13
B Purchase
16,106 -45.8%
18.44
US$4,872,489 		16,106 -45.8% 18.44 US$4,872,489
2008-11-14 2008-11-13
B Purchase
600 +2.1%
3.20
US$1,920 		600 +2.1% 3.20 US$1,920
2008-11-14 2008-11-13
B Purchase
2,873 +11.4%
3.19
US$9,165 		2,873 +11.4% 3.19 US$9,165